St. Jude Medical (NYSE:STJ) said today that it’s launching its Optis Mobile OCT-FFR lab in Europe and Japan.
Little Canada, Minn.-based St. Jude said the portable Optis Mobile is designed for hospitals with multiple cardiac catheterization labs and combines optical coherence tomography and angiography co-registration with fractional flow reserve.
“The Optis Mobile system represents the ongoing commitment of St. Jude Medical to develop products that provide physicians with more options for improved OCT and angiography co-registration guidance in their daily practice,” group president Dr. Eric Fain said in prepared remarks. “In contrast with intravascular ultrasound, OCT offers increased resolution and highly-detailed intracoronary arterial views, which can improve PCI procedures, especially in complex cases.”
“As the interventional cardiology landscape continues to expand, there is a real need for more portable intravascular imaging systems to ensure hospitals with multiple catheterization labs have the right technology available for physicians to make more informed treatment decisions during PCI,” added Dr. Nick West of Cambridge, U.K.’s Papworth Hospital. “The imaging advancements offered with the Optis mobile system provide the same benefits of theOptis Integrated System, and allow physicians to clearly visualize complex cardiac anatomy and evaluate how to best proceed during [precutaneous coronary intervention].”